View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
THURSDAY, Oct. 20 (HealthDay News) -- Infants 2 years old and younger cannot be vaccinated against pertussis, so other strategies are needed to protect this age group from the potentially fatal condition; therefore, tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) booster vaccines are being recommended for those who have close contact with infants, according to a report published in the Oct. 21 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
Since 2005, the Advisory Committee on Immunization Practices (ACIP) has recommended Tdap booster vaccinations to unvaccinated postpartum mothers along with cocooning programs (i.e., vaccinating family members of newborns) to reduce the rate of pertussis-associated infant death, but cocooning programs have had limited success in vaccinating fathers and other family members.
In June of 2011, the ACIP presented updated recommendations on the use of Tdap in unvaccinated pregnant women and cocooning. They recommend administration of Tdap vaccination to previously unvaccinated pregnant women after 20 weeks' gestation or immediately postpartum, and that family members who will have close contact with the newborn also receive a Tdap dose if they have not received one previously.
"These updated recommendations on use of Tdap in pregnant women are consistent with the goal of reducing the burden of pertussis in infants," the authors write.
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top